# Effects of Dexmedetomidine During Radiofrequency Ablation of Abdominal Tumours

> **NCT02016391** · PHASE4 · COMPLETED · sponsor: **Uppsala University Hospital** · enrollment: 50 (actual)

## Conditions studied

- Cancer of Kidney and Renal Pelvis
- Cancer of Liver

## Interventions

- **DRUG:** Dexmedetomidine

## Key facts

- **NCT ID:** NCT02016391
- **Lead sponsor:** Uppsala University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2014-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02016391

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02016391, "Effects of Dexmedetomidine During Radiofrequency Ablation of Abdominal Tumours". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02016391. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*